• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

从一名患有致心律失常性心肌病且携带c.2013delC PKP2突变的患者中生成人类诱导多能干细胞系LUMCi027-A及其等基因校正系。

Generation of human induced pluripotent stem cell line LUMCi027-A and its isogenic gene-corrected line from a patient affected by arrhythmogenic cardiomyopathy and carrying the c.2013delC PKP2 mutation.

作者信息

Meraviglia Viviana, Arendzen Christiaan H, Tok Merve, Freund Christian, Maione Angela Serena, Sommariva Elena, Bellin Milena

机构信息

Department of Anatomy and Embryology, Leiden University Medical Center, Leiden, The Netherlands.

Department of Anatomy and Embryology, Leiden University Medical Center, Leiden, The Netherlands; Leiden University Medical Center hiPSC Hotel, Leiden, The Netherlands.

出版信息

Stem Cell Res. 2020 Jul;46:101835. doi: 10.1016/j.scr.2020.101835. Epub 2020 May 5.

DOI:10.1016/j.scr.2020.101835
PMID:32485643
Abstract

Arrhythmogenic Cardiomyopathy (ACM) is a rare inherited heart muscle disease characterised by progressive fibro-fatty replacement of the ventricular myocardium leading to life-threatening arrhythmias. We generated human induced pluripotent stem cells (hiPSCs) from a patient affected by ACM and carrying the heterozygous c.2013delC (p.K672Rfs) PKP2 mutation and then corrected the mutation using CRISPR/Cas9 technology. Both hiPSC lines expressed pluripotency markers, maintained a normal karyotype, and differentiated into derivatives of the three germ layers. This isogenic hiPSC pair represents a genetically controlled system to study the role of the c.2013delC PKP2 mutation in vitro.

摘要

致心律失常性心肌病(ACM)是一种罕见的遗传性心肌疾病,其特征是心室心肌进行性纤维脂肪替代,导致危及生命的心律失常。我们从一名患有ACM且携带杂合子c.2013delC(p.K672Rfs)PKP2突变的患者身上获取了人诱导多能干细胞(hiPSC),然后使用CRISPR/Cas9技术纠正了该突变。这两个hiPSC系均表达多能性标志物,保持正常核型,并分化为三个胚层的衍生物。这一对同基因hiPSC代表了一个基因可控系统,用于在体外研究c.2013delC PKP2突变的作用。

相似文献

1
Generation of human induced pluripotent stem cell line LUMCi027-A and its isogenic gene-corrected line from a patient affected by arrhythmogenic cardiomyopathy and carrying the c.2013delC PKP2 mutation.从一名患有致心律失常性心肌病且携带c.2013delC PKP2突变的患者中生成人类诱导多能干细胞系LUMCi027-A及其等基因校正系。
Stem Cell Res. 2020 Jul;46:101835. doi: 10.1016/j.scr.2020.101835. Epub 2020 May 5.
2
Generation of human induced pluripotent stem cell line EURACi006-A and its isogenic gene-corrected line EURACi006-A-1 from an arrhythmogenic cardiomyopathy patient carrying the c.1643delG PKP2 mutation.从一位携带 c.1643delG PKP2 突变的致心律失常性心肌病患者中生成人诱导多能干细胞系 EURACi006-A 及其同基因校正系 EURACi006-A-1。
Stem Cell Res. 2021 Jul;54:102426. doi: 10.1016/j.scr.2021.102426. Epub 2021 Jun 8.
3
Derivation of human induced pluripotent stem cell line EURACi004-A from skin fibroblasts of a patient with Arrhythmogenic Cardiomyopathy carrying the heterozygous PKP2 mutation c.2569_3018del50.从一名携带杂合性PKP2突变c.2569_3018del50的致心律失常性心肌病患者的皮肤成纤维细胞中衍生出人类诱导多能干细胞系EURACi004-A。
Stem Cell Res. 2018 Oct;32:78-82. doi: 10.1016/j.scr.2018.09.003. Epub 2018 Sep 6.
4
CRISPR/Cas9-edited PKP2 knock-out (JMUi001-A-2) and DSG2 knock-out (JMUi001-A-3) iPSC lines as an isogenic human model system for arrhythmogenic cardiomyopathy (ACM).CRISPR/Cas9 编辑的 PKP2 敲除(JMUi001-A-2)和 DSG2 敲除(JMUi001-A-3)iPSC 系作为致心律失常性心肌病(ACM)的同基因人模型系统。
Stem Cell Res. 2021 May;53:102256. doi: 10.1016/j.scr.2021.102256. Epub 2021 Feb 18.
5
Generation of two edited iPSCs lines by CRISPR/Cas9 with point mutations in PKP2 gene for arrhythmogenic cardiomyopathy in vitro modeling.通过 CRISPR/Cas9 在 PKP2 基因中产生点突变,生成两条用于心律失常性心肌病体外建模的编辑 iPSC 系。
Stem Cell Res. 2023 Sep;71:103157. doi: 10.1016/j.scr.2023.103157. Epub 2023 Jun 25.
6
Generation and characterization of three human induced pluripotent stem cell lines (EURACi007-A, EURACi008-A, EURACi009-A) from three different individuals of the same family with arrhythmogenic cardiomyopathy (ACM) carrying the plakophillin2 p.N346Lfs*12 mutation.从一个患有心律失常性心肌病 (ACM) 的同一家族的三个不同个体中生成并鉴定了三个人类诱导多能干细胞系 (EURACi007-A、EURACi008-A 和 EURACi009-A),这些个体均携带斑联素 2 p.N346Lfs*12 突变。
Stem Cell Res. 2021 Aug;55:102466. doi: 10.1016/j.scr.2021.102466. Epub 2021 Jul 15.
7
Generation of CRISPR/Cas9 edited human induced pluripotent stem cell line carrying the heterozygous p.H695VfsX5 frameshift mutation in the exon 10 of the PKP2 gene.生成携带 PKP2 基因第 10 外显子中杂合 p.H695VfsX5 移码突变的 CRISPR/Cas9 编辑人诱导多能干细胞系。
Stem Cell Res. 2024 Apr;76:103341. doi: 10.1016/j.scr.2024.103341. Epub 2024 Feb 13.
8
Generation of an induced pluripotent stem cell line from the dermal fibroblasts of a patient with arrhythmogenic right ventricular cardiomyopathy carrying a PKP2/c.2489 + 1G > A mutation.从一名携带PKP2/c.2489 + 1G>A突变的致心律失常性右室心肌病患者的皮肤成纤维细胞中生成诱导多能干细胞系。
Stem Cell Res. 2020 Oct;48:101965. doi: 10.1016/j.scr.2020.101965. Epub 2020 Aug 27.
9
Generation of three induced pluripotent stem cell lines, SCVIi003-A, SCVIi004-A, SCVIi005-A, from patients with ARVD/C caused by heterozygous mutations in the PKP2 gene.从 PKP2 基因杂合突变导致的 ARVD/C 患者中生成三个诱导多能干细胞系,SCVIi003-A、SCVIi004-A、SCVIi005-A。
Stem Cell Res. 2021 May;53:102284. doi: 10.1016/j.scr.2021.102284. Epub 2021 Mar 12.
10
Establishment of an arrhythmogenic right ventricular cardiomyopathy derived iPSC cell line (USFi004-A) carrying a heterozygous mutation in PKP2 (c.1799delA).致心律失常性右室心肌病诱导多能干细胞系(USFi004-A)的建立,携带 PKRP2 基因杂合突变(c.1799delA)。
Stem Cell Res. 2021 Jul;54:102398. doi: 10.1016/j.scr.2021.102398. Epub 2021 May 19.

引用本文的文献

1
Cardiomyocyte and stromal cell cross-talk influences the pathogenesis of arrhythmogenic cardiomyopathy: a multi-level analysis uncovers DLK1-NOTCH pathway role in fibro-adipose remodelling.心肌细胞与基质细胞的相互作用影响致心律失常性心肌病的发病机制:多层次分析揭示DLK1-NOTCH通路在纤维脂肪重塑中的作用。
Cell Death Discov. 2024 Nov 28;10(1):484. doi: 10.1038/s41420-024-02232-8.
2
Modeling Cardiomyopathies in a Dish: State-of-the-Art and Novel Perspectives on hiPSC-Derived Cardiomyocytes Maturation.培养皿中的心肌病建模:人诱导多能干细胞衍生心肌细胞成熟的最新进展与新视角
Biology (Basel). 2021 Jul 30;10(8):730. doi: 10.3390/biology10080730.
3
Generation, functional analysis and applications of isogenic three-dimensional self-aggregating cardiac microtissues from human pluripotent stem cells.
从人类多能干细胞中生成、功能分析和应用同基因三维自聚集心脏微组织。
Nat Protoc. 2021 Apr;16(4):2213-2256. doi: 10.1038/s41596-021-00497-2. Epub 2021 Mar 26.
4
Mechanotransduction and Adrenergic Stimulation in Arrhythmogenic Cardiomyopathy: An Overview of and Models.致心律失常性心肌病中的机械转导与肾上腺素能刺激:概述与模型
Front Physiol. 2020 Nov 12;11:568535. doi: 10.3389/fphys.2020.568535. eCollection 2020.